These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

94 related items for PubMed ID: 2797345

  • 1. Moderately proteinuric IgA nephropathy: prognostic prediction of individual clinical courses and steroid therapy in progressive cases.
    Kobayashi Y, Hiki Y, Fujii K, Kurokawa A, Tateno S.
    Nephron; 1989; 53(3):250-6. PubMed ID: 2797345
    [Abstract] [Full Text] [Related]

  • 2. Steroid therapy in IgA nephropathy: a retrospective study in heavy proteinuric cases.
    Kobayashi Y, Fujii K, Hiki Y, Tateno S, Kurokawa A, Kamiyama M.
    Nephron; 1988; 48(1):12-7. PubMed ID: 3340251
    [Abstract] [Full Text] [Related]

  • 3. Steroid therapy during the early stage of progressive IgA nephropathy. A 10-year follow-up study.
    Kobayashi Y, Hiki Y, Kokubo T, Horii A, Tateno S.
    Nephron; 1996; 72(2):237-42. PubMed ID: 8684533
    [Abstract] [Full Text] [Related]

  • 4. The effectiveness of steroid therapy for patients with advanced IgA nephropathy and impaired renal function.
    Moriyama T, Honda K, Nitta K, Yumura W, Nihei H.
    Clin Exp Nephrol; 2004 Sep; 8(3):237-42. PubMed ID: 15480901
    [Abstract] [Full Text] [Related]

  • 5. [Prognostic significance of persistent massive proteinuria in progressive IgA nephropathy--a long-term follow-up study].
    Kokubo T, Hiki Y, Tateno S, Kobayashi Y.
    Nihon Jinzo Gakkai Shi; 1994 Jul; 36(7):823-31. PubMed ID: 8072220
    [Abstract] [Full Text] [Related]

  • 6. Steroid therapy in IgA nephropathy: a prospective pilot study in moderate proteinuric cases.
    Kobayashi Y, Fujii K, Hiki Y, Tateno S.
    Q J Med; 1986 Oct; 61(234):935-43. PubMed ID: 3628707
    [Abstract] [Full Text] [Related]

  • 7. Effect of corticosteroid therapy on the progression of IgA nephropathy with moderate proteinuria.
    Uzu T, Harada T, Ko M, Yamato M, Takahara K, Yamauchi A.
    Clin Exp Nephrol; 2003 Sep; 7(3):210-4. PubMed ID: 14586717
    [Abstract] [Full Text] [Related]

  • 8. IgA nephropathy: heterogeneous clinical pictures and steroid therapy in progressive cases.
    Kobayashi Y, Hiki Y, Fujii K, Kurokawa A, Kamiyana M, Tateno S.
    Semin Nephrol; 1987 Dec; 7(4):382-5. PubMed ID: 3445022
    [No Abstract] [Full Text] [Related]

  • 9. Comparison of antiproteinuric effects of two different combination therapies in children with IgA nephropathy.
    Yagi K, Okada M, Yanagida H, Kuwajima H, Ikeda M, Sugimoto K, Takemura T.
    Clin Exp Nephrol; 2003 Dec; 7(4):270-4. PubMed ID: 14712355
    [Abstract] [Full Text] [Related]

  • 10. Predictors for progression in immunoglobulin A nephropathy with significant proteinuria.
    Hwang HS, Kim BS, Shin YS, Yoon HE, Song JC, Choi BS, Park CW, Yang CW, Kim YS, Bang BK.
    Nephrology (Carlton); 2010 Mar; 15(2):236-41. PubMed ID: 20470285
    [Abstract] [Full Text] [Related]

  • 11. Randomized controlled clinical trial of corticosteroids plus ACE-inhibitors with long-term follow-up in proteinuric IgA nephropathy.
    Manno C, Torres DD, Rossini M, Pesce F, Schena FP.
    Nephrol Dial Transplant; 2009 Dec; 24(12):3694-701. PubMed ID: 19628647
    [Abstract] [Full Text] [Related]

  • 12. Multivariate analysis of prognostic factors and effect of treatment in patients with IgA nephropathy.
    Komatsu H, Fujimoto S, Hara S, Sato Y, Yamada K, Eto T, Nakao H.
    Ren Fail; 2005 Dec; 27(1):45-52. PubMed ID: 15717634
    [Abstract] [Full Text] [Related]

  • 13. Nephrotic range proteinuria--a good predictive index of disease in IgA nephropathy?
    Lai KN, Ho CP, Chan KW, Yan KW, Lai FM, Vallance-Owen J.
    Q J Med; 1985 Oct; 57(222):677-88. PubMed ID: 4080957
    [Abstract] [Full Text] [Related]

  • 14. Treatment of IgA nephropathy.
    Pozzi C.
    J Nephrol; 2016 Feb; 29(1):21-5. PubMed ID: 26577268
    [Abstract] [Full Text] [Related]

  • 15. Comparison of steroids and angiotensin receptor blockers for patients with advanced IgA nephropathy and impaired renal function.
    Moriyama T, Amemiya N, Ochi A, Tsuruta Y, Shimizu A, Itabashi M, Takei T, Uchida K, Nitta K.
    Am J Nephrol; 2011 Feb; 34(3):233-40. PubMed ID: 21778707
    [Abstract] [Full Text] [Related]

  • 16. Mycophenolate mofetil therapy for steroid-resistant IgA nephropathy with the nephrotic syndrome in children.
    Kang Z, Li Z, Duan C, Wu T, Xun M, Ding Y, Zhang Y, Zhang L, Yin Y.
    Pediatr Nephrol; 2015 Jul; 30(7):1121-9. PubMed ID: 25773534
    [Abstract] [Full Text] [Related]

  • 17. Immunosuppressive therapy in patients with IgA nephropathy.
    Peters HP, van den Brand JA, Berger SP, Wetzels JF.
    Neth J Med; 2015 Jul; 73(6):284-9. PubMed ID: 26228193
    [Abstract] [Full Text] [Related]

  • 18. Significance of clinical and morphological prognostic risk factors in IgA nephropathy: follow-up study of comparison patient groups with and without renoprotection.
    Riispere Ž, Kuudeberg A, Seppet E, Sepp K, Ilmoja M, Luman M, Kõlvald K, Auerbach A, Ots-Rosenberg M.
    BMC Nephrol; 2017 Mar 14; 18(1):89. PubMed ID: 28292274
    [Abstract] [Full Text] [Related]

  • 19. The influence of pregnancy on the long-term renal prognosis of IgA nephropathy.
    Abe S.
    Clin Nephrol; 1994 Feb 14; 41(2):61-4. PubMed ID: 8004830
    [Abstract] [Full Text] [Related]

  • 20. [Comparative studies of clinicopathological findings in patients with adult and juvenile onset of IgA nephropathy].
    Yaguchi Y, Tomino Y, Nakamura T, Funabiki K, Shirato I, Ebiiiara I, Nakayama S, Koide H.
    Nihon Jinzo Gakkai Shi; 1989 Jul 14; 31(7):729-33. PubMed ID: 2585826
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.